492 related articles for article (PubMed ID: 28893175)
1. Chronic kidney disease and diabetes associated with long-term outcomes in patients receiving percutaneous coronary intervention.
Lin MJ; Lee J; Chen CY; Huang CC; Wu HP
BMC Cardiovasc Disord; 2017 Sep; 17(1):242. PubMed ID: 28893175
[TBL] [Abstract][Full Text] [Related]
2. Impact of diabetes and hypertension on cardiovascular outcomes in patients with coronary artery disease receiving percutaneous coronary intervention.
Lin MJ; Chen CY; Lin HD; Wu HP
BMC Cardiovasc Disord; 2017 Jan; 17(1):12. PubMed ID: 28056847
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous coronary intervention reduces mortality in myocardial infarction patients with comorbidities: Implications for elderly patients with diabetes or kidney disease.
Dégano IR; Subirana I; Fusco D; Tavazzi L; Kirchberger I; Farmakis D; Ferrières J; Azevedo A; Torre M; Garel P; Brosa M; Davoli M; Meisinger C; Bongard V; Araújo C; Lekakis J; Francès A; Castell C; Elosua R; Marrugat J;
Int J Cardiol; 2017 Dec; 249():83-89. PubMed ID: 29121766
[TBL] [Abstract][Full Text] [Related]
4. Outcomes with prolonged clopidogrel therapy after coronary stenting in patients with chronic kidney disease.
Siddiqi OK; Smoot KJ; Dufour AB; Cho K; Young M; Gagnon DR; Ly S; Temiyasathit S; Faxon DP; Gaziano JM; Kinlay S
Heart; 2015 Oct; 101(19):1569-76. PubMed ID: 26209334
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of STEMI patients with chronic kidney disease treated with percutaneous coronary intervention: the Malaysian National Cardiovascular Disease Database - Percutaneous Coronary Intervention (NCVD-PCI) registry data from 2007 to 2014.
Ismail MD; Jalalonmuhali M; Azhari Z; Mariapun J; Lee ZV; Zainal Abidin I; Wan Ahmad WA; Zuhdi ASM;
BMC Cardiovasc Disord; 2018 Sep; 18(1):184. PubMed ID: 30249197
[TBL] [Abstract][Full Text] [Related]
6. Revascularization in Patients With Multivessel Coronary Artery Disease and Chronic Kidney Disease: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL
J Am Coll Cardiol; 2015 Sep; 66(11):1209-1220. PubMed ID: 26361150
[TBL] [Abstract][Full Text] [Related]
7. The impact of stage of chronic kidney disease on the outcomes of diabetics with acute myocardial infarction treated with percutaneous coronary intervention.
Vichova T; Knot J; Ulman J; Maly M; Motovska Z
Int Urol Nephrol; 2016 Jul; 48(7):1137-43. PubMed ID: 26995007
[TBL] [Abstract][Full Text] [Related]
8. Long-term clinical outcomes of percutaneous coronary intervention for chronic total occlusions in patients with versus without diabetes mellitus.
Claessen BE; Dangas GD; Godino C; Lee SW; Obunai K; Carlino M; Suh JW; Leon MB; Di Mario C; Park SJ; Stone GW; Moses JW; Colombo A; Mehran R;
Am J Cardiol; 2011 Oct; 108(7):924-31. PubMed ID: 21820095
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Relation Between Severity of Diabetes Mellitus (On or Off Insulin) ± Chronic Kidney Disease with Cardiovascular Risk After Percutaneous Coronary Intervention.
Chamaria S; Bhatheja S; Vengrenyuk Y; Sweeny J; Choudhury H; Barman N; Mehran R; Sharma S; Baber U; Kini A
Am J Cardiol; 2018 Jan; 121(2):168-176. PubMed ID: 29187288
[TBL] [Abstract][Full Text] [Related]
10. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.
Nakahashi H; Kosuge M; Sakamaki K; Kiyokuni M; Ebina T; Hibi K; Tsukahara K; Iwahashi N; Kuji S; Oba MS; Umemura S; Kimura K
Heart Vessels; 2017 Jan; 32(1):22-29. PubMed ID: 27106917
[TBL] [Abstract][Full Text] [Related]
11. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
[TBL] [Abstract][Full Text] [Related]
12. Five-year mortality outcomes in patients with chronic kidney disease undergoing percutaneous coronary intervention.
Patel AD; Ibrahim M; Swaminathan RV; Minhas IU; Kim LK; Venkatesh P; Feldman DN; Minutello RM; Bergman GW; Wong SC; Singh HS
Catheter Cardiovasc Interv; 2017 Mar; 89(4):E124-E132. PubMed ID: 27519355
[TBL] [Abstract][Full Text] [Related]
13. Impact of chronic kidney disease on clinical outcomes in patients with non-ST elevation myocardial infarction receiving percutaneous coronary intervention - A five-year observational study.
Wang HT; Chen YL; Wu CJ
Int J Cardiol; 2016 Oct; 220():166-72. PubMed ID: 27379919
[TBL] [Abstract][Full Text] [Related]
14. Hypertension and chronic kidney disease affect long-term outcomes in patients with stable coronary artery disease receiving percutaneous coronary intervention.
Lin MJ; Yang WC; Chen CY; Huang CC; Chuang HY; Gao FX; Wu HP
Sci Rep; 2018 Dec; 8(1):17673. PubMed ID: 30518771
[TBL] [Abstract][Full Text] [Related]
15. Comparative Effectiveness of Medical Therapy, Percutaneous Revascularization, and Surgical Coronary Revascularization in Cardiovascular Risk Subgroups of Patients With CKD: A Retrospective Cohort Study of Medicare Beneficiaries.
Charytan DM; Natwick T; Solid CA; Li S; Gong T; Herzog CA
Am J Kidney Dis; 2019 Oct; 74(4):463-473. PubMed ID: 31255335
[TBL] [Abstract][Full Text] [Related]
16. Influence of diabetes mellitus on clinical outcomes following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Jensen LO; Maeng M; Thayssen P; Tilsted HH; Terkelsen CJ; Kaltoft A; Lassen JF; Hansen KN; Ravkilde J; Christiansen EH; Madsen M; Sørensen HT; Thuesen L
Am J Cardiol; 2012 Mar; 109(5):629-35. PubMed ID: 22152969
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Outcomes in Patients With Diabetes Mellitus Related to Prolonging Clopidogrel More Than 12 Months After Coronary Stenting.
Thukkani AK; Agrawal K; Prince L; Smoot KJ; Dufour AB; Cho K; Gagnon DR; Sokolovskaya G; Ly S; Temiyasathit S; Faxon DP; Gaziano JM; Kinlay S
J Am Coll Cardiol; 2015 Sep; 66(10):1091-101. PubMed ID: 26337986
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous Intervention for Myocardial Infarction After Noncardiac Surgery: Patient Characteristics and Outcomes.
Parashar A; Agarwal S; Krishnaswamy A; Sud K; Poddar KL; Bassi M; Ellis S; Tuzcu EM; Menon V; Kapadia SR
J Am Coll Cardiol; 2016 Jul; 68(4):329-38. PubMed ID: 27443427
[TBL] [Abstract][Full Text] [Related]
19. Impact of Mild-to-Moderate Chronic Kidney Disease on One Year Outcomes after Percutaneous Coronary Intervention.
Grandjean-Thomsen NL; Marley P; Shadbolt B; Farshid A
Nephron; 2017; 137(1):23-28. PubMed ID: 28478459
[TBL] [Abstract][Full Text] [Related]
20. Chronic kidney disease and the risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents.
Miao Y; Yu-Jie Z; Zhi-Jian W; Dong-Mei S; Yu-Yang L; Ying-Xin Z; Fei G; Shi-Wei Y; De-An J
Catheter Cardiovasc Interv; 2012 Sep; 80(3):361-7. PubMed ID: 22419375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
